By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Sign up for the quarterly PTPAC newsletter, featuring articles on the importance of PTPAC on Capitol Hill, what's happening in election races across the country, and PTPAC events at conferences.
Jan 6, 2022/Video
Join Beth Sarfaty, PT, MBA, as she explores mentorship related to personal and professional growth.
Mar 23, 2026/Article
APTA Board member Kelley Kubota, PT, DPT, MS, moderated the John H.P. Maley Clinical Impact Lectureship Award panel featuring William Boissonnault, PT, DPT, DHSc, FAPTA, Andrea Behrman, PT, PhD, FAPTA, and Nicole Stout, PT, DPT, FAPTA. For the 31st annual John H.P. Maley Clinical Impact Lectureship Award,
Jun 29, 2017/Test & Measure
A 13-item questionnaire designed to provide both a patient and a caregiver report of the quality of life (QOL) for patients who have been diagnosed with Alzheimer Disease (AD).
Oct 30, 2023/Roundup
Learn about a landmark APTA report, explore APTA's new research agenda, share in one PT's professional journey, and more.
Apr 2, 2024/News
After helping create the CPT codes and advocate for their adoption, APTA launched an education campaign featuring a practice advisory.
Jan 5, 2022/News
APTA continues to advocate for changes that reflect the realities of physical therapy and patient-centered care.
Dec 22, 2021/Article
The Education Leadership Partnership, a collaboration between APTA, ACAPT, and the Academy of Education, completed its charge with the published report "A Vision of Excellence in Physical Therapy Education."
May 5, 2026/Article
The Centers for Medicare & Medicaid Services has released its Medicare Advantage Contract Year 2027 Final Rule, finalizing policies related to utilization management, special needs plans, and supplemental benefits. While the rule does not directly address physical therapist payment or scope of practice,
Oct 31, 2021/Test & Measure
The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.1
